Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ), and ATG-Fresenius (ATG-FRES), with respect to do...
Main Authors: | Lisa V. E. Oostenbrink, Cornelia M. Jol-van der Zijde, Katrine Kielsen, Anja M. Jansen-Hoogendijk, Marianne Ifversen, Klaus G. Müller, Arjan C. Lankester, Astrid G. S. van Halteren, Robbert G. M. Bredius, Marco W. Schilham, Maarten J. D. van Tol |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00315/full |
Similar Items
-
Biopolymer production using fungus Mucor racemosus Fresenius and glycerol as substrate
by: Thaíssa Rodrigues Araújo, et al. -
How to Improve a Planning System and Workflow in a Quality Control Laboratory : A Case Study at Fresenius Kabi in Sweden
by: Eminovic, Nejra, et al.
Published: (2021) -
Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Turun Song, et al.
Published: (2020-04-01) -
The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease
by: Robert Ali, et al.
Published: (2017-11-01) -
Operational management through key performance Indicators : A case study performed at the warehouses at Fresenius Kabi
by: Salin Gustafsson, Martin, et al.
Published: (2018)